Does TREPROSTINIL Cause Pulmonary hypertension? 1,931 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,931 reports of Pulmonary hypertension have been filed in association with TREPROSTINIL (TYVASO). This represents 2.1% of all adverse event reports for TREPROSTINIL.
1,931
Reports of Pulmonary hypertension with TREPROSTINIL
2.1%
of all TREPROSTINIL reports
608
Deaths
1,420
Hospitalizations
How Dangerous Is Pulmonary hypertension From TREPROSTINIL?
Of the 1,931 reports, 608 (31.5%) resulted in death, 1,420 (73.5%) required hospitalization, and 101 (5.2%) were considered life-threatening.
Is Pulmonary hypertension Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 1,931 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Pulmonary hypertension?
MACITENTAN (1,505)
AMBRISENTAN (1,504)
SELEXIPAG (681)
EPOPROSTENOL (591)
SILDENAFIL (517)
BOSENTAN (504)
TADALAFIL (428)
RIOCIGUAT (411)
ADALIMUMAB (287)
DASATINIB (249)
Which TREPROSTINIL Alternatives Have Lower Pulmonary hypertension Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE